Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone increases muscle mass regardless of DHT conversion blocking.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Thicker scalp fat may link hair loss with metabolic syndrome.

Testosterone's muscle-building effects do not require its conversion to DHT.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Low estrogen due to poor nutrition can lead to non-alcoholic fatty liver disease.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Broiler chicken meat extract increases body weight, visceral fat, and hair production in young male Wistar rats.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Alopecia areata may be linked to changes in body fat but not to heart or artery issues.

Low-dose flutamide-metformin therapy effectively improved PCOS symptoms in adolescent girls.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Women with PCOS have higher body fat and worse insulin resistance and lipid profiles.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Removing REDD1 in mice increases skin fat by making fat cells larger and more numerous.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.